Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Pharmacyclics

Imbruvica shines in combination trial

Imbruvica shines in combination trial Showed significant increase in progression-free survival.  . A phase III trial of Johnson &Johnson (J&J) and Pharmacyclics' Imbruvica in combination with two other drugs has been halted early after the ... The data from the trial will form the basis of

AbbVie to acquire cancer biopharma Pharmacyclics for $21bn

AbbVie to acquire cancer biopharma Pharmacyclics for $21bn Deutsche Bank analyst Robyn Karnauskas said in a note to clients that the Pharmacyclics deal was 'positive' for AbbVie, predominately because of Pharmacyclics' blood cancer treatment Imbruvica(Ibrutinib), which will help ... Pharmacyclics expects US

Novartis gets OK for panobinostat in myeloma

Novartis gets OK for panobinostat in myeloma Servier abandoned development of its abexinostat candidate last year, returning rights to the drug to its originator Pharmacyclics.

Imbruvica gets FDA OK for rare lymphoma

Imbruvica gets FDA OK for rare lymphoma The drug is a Bruton's tyrosine kinase (BTK) inhibitor - licensed by J&J from Pharmacyclics in 2011 in a deal valued at up to $975m - and is also approved to

MedImmune partners with US National Cancer Institute

MedImmune partners with US National Cancer Institute AZ has several research collaborations involving MEDI4736 , including one with Advaxis that was signed in July last year, as well as deals with Johnson &Johnson and Pharmacyclics to test various combinations

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics